Sun Pharmaceutical Industries Ltd

Common Name
Sun Pharmaceutical Industries
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
43,000
Ticker
SUNPHARMA
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Sun Pharmaceutical Industries Ltd. is a major player in the global pharmaceutical industry, specializing in the manufacturing and marketing of a broad array of pharmaceutical formulations and active p...

Financial Statements of Sun Pharmaceutical Industries

Below are the financial statements of Sun Pharmaceutical Industries, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of INR20252024
Revenue from operations
525,784.4a
484,968.5a
Other income
19,650.4a
13,541.9a
Total income
545,434.8a
498,510.4a
Expenses
Cost of materials consumed
-64,491a
-69,043.3a
Purchases of stock-in-trade
-41,479.5a
-34,661.5a
Changes in inventories of finished goods, stock-in-trade and work-in-progress
-1,503.1a
-2,921.3a
Employee benefits expense
-99,731.2a
-94,290.6a
Finance costs
-2,313.6a
-2,384.7a
Depreciation and amortisation expense
-25,753.9a
-25,566.4a
Other expenses
-167,718a
-154,181.8a
Net (gain) / loss on foreign currency transactions
-1,855.3a
-361.3a
Total expenses
-401,135a
-382,688.3a
Profit before exceptional items and tax
144,299.8a
115,822.1a
Exceptional items
6,778.5a
4,943.2a
Profit before tax
137,521.3a
110,878.9a
Tax expense / (credit)
Current tax
-33,200.5a
-19,893a
Deferred tax
-9,255a
-5,498.5a
Deferred tax - exceptional
-3,774.8a
0a
Total tax expense
-27,720.3a
-14,394.5a
Profit for the year before share of profit / (loss) of associates and joint venture
109,801a
96,484.4a
Share of profit / (loss) of associates (net of tax)
-252.2a
-382.7a
Share of profit / (loss) of joint venture (net of tax)
98.7a
-1.4a
Profit for the year before non-controlling interests
109,647.5a
96,100.3a
Non-controlling interests
357.1a
336.5a
Profit for the year attributable to owners of the parent company
109,290.4a
95,763.8a

Verified Sources Behind Sun Pharmaceutical Industries’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sun Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.

a. Sun Pharmaceutical Industries's Annual Report 2025
Trace every data point back to Sun Pharmaceutical Industries’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?